The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: By blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets

Asia Pacific Journal of Clinical Nutrition

Volumn 17, Issue SUPPL. 1, 2008, Pages 204-207

  Na, Hye Kyung ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; COX 2; Edelfosine; ET 18 O CH3; MCF10A ras cells

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; EDELFOSINE; ETHER PHOSPHOLIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2;

APOPTOSIS; ARTICLE; BREAST; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; ONCOGENE RAS; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; DINOPROSTONE; EPITHELIAL CELLS; GENES, RAS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPID ETHERS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 46049092032     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 3, is mediated by inhibition of cytokinesis. Cancer Chemother Pharmacol. 2003;51:209-215.
2. 3. Cancer Chemother Pharmacol. 1994;34:175-178.
3. Shafer SH, Williams CL. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment. Int J Oncol. 2003;23:389-400.
4. 3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res. 1997;57:1320-1328.
5. Jendrossek V, Handrick R. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. Curr Med Chem Anticancer Agents. 2003;3:343-353.
6. van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, van Blitterswijk WJ. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther. 2007;6:2337-2345.
7. Guo HB, Shen ZH, Huang CX, Ma J, Huang Y, Chen HL. Modulation of the basal activity of phosphatidylinositol-3-kinase/protein kinase B signaling pathway in human hepatocarcinoma cells. Glycoconj J. 2000;17:315-322.
8. Winkler JD, Eris T, Sung CM, Chabot-Fletcher M, Mayer RJ, Surette ME, Chilton FH. Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells. J Pharmacol Exp Ther. 1996;279:956-966.
9. Surette ME, Winkler JD, Fonteh AN, Chilton FH. Relationship between arachidonate - phospholipid remodeling and apoptosis. Biochemistry. 1996;35:9187-9196.
10. Civoli F, Daniel LW. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines. Cancer Chemother Pharmacol. 1998;42:319-326.
11. Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711-719.
12. Ishiko O, Sumi T, Yoshida H, Matsumoto Y, Honda K, Deguchi M, Yamada R, Ogita S. Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion. Oncol Rep. 2001;8:1259-1263.
13. Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology. 2001;121:1339-1347.
14. Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst. 2006;98:736-747.
15. Chun KS, Kim SH, Song YS, Surh YJ. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis. 2004;25:713-722.
16. Davaille J, Gallois C, Habib A, Li L, Mallat A, Tao J, Levade T, Lotersztajn S. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. J Biol Chem. 2000;275:34628-34633.
17. Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K. Upregulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol. 2004;66:1643-1651.
18. Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM, Santoro MG. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IκB kinase/nuclear factor-kappa-B pathway. Mol Pharmacol. 2006;70:1812-1821.
19. 3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells. FEBS Lett. 2005;579:6279-6287.
20. Karin M. Nuclear factor-κB in cancer development and progression. Nature. 2006;441:431-436.
21. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. Co-operative functions between nuclear factors NFκB and CCAT/enhancer-binding protein-beta (C/EBP-β) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate. 2004;61:354-370.
22. Yalcin A, Koulich E, Mohamed S, Liu L, D'Mello SR. Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB-binding protein and NF-κB. J Neurochem. 2003;84:397-408.
23. kB2/p100 induces Bcl-2 expression. Leukemia. 2003;17:1349-1356.